Literature DB >> 7673210

Purification and characterization of the Mycobacterium smegmatis catalase-peroxidase involved in isoniazid activation.

J A Marcinkeviciene1, R S Magliozzo, J S Blanchard.   

Abstract

The unique antitubercular activity of isoniazid requires that the drug be oxidized by the katG-encoded mycobacterial catalase-peroxidase to an activated drug form. In order to quantitatively assess the catalytic capabilities of the enzyme, the native catalase-peroxidase from Mycobacterium smegmatis was purified over 200-fold to homogeneity. The enzyme was shown to exhibit both catalase and peroxidase activities, and in the presence of either hydrogen peroxide or t-butyl peroxide, was found to catalyze the oxidation of the reduced pyridine nucleotides, NADH and NADPH, as well as artificial peroxidase substrates, at rates between 2.7 and 20 s-1. The homogeneous enzyme exhibited a visible absorbance spectrum typical of ferric heme-containing catalase-peroxidases, with a Soret maximum at 406 nm. Low temperature (10 K) electron paramagnetic resonance spectra in the presence of ethylene glycol revealed a high spin Fe(III) signal with g values of 5.9 and 5.6. The enzyme was very slowly (t1/2 = approximately 20 min) reduced by dithionite, and the reduced form showed typical spectral changes when either KCN or CO were subsequently added. The M. smegmatis catalase-peroxidase was found to contain 2 heme molecules per tetramer, which were identified as iron protoporphyrin IX by the pyridine hemochromogen assay. The peroxidatic activity was inhibited by KCN, NaN3, isoniazid (isonicotinic acid hydrazide), and its isomer, nicotinic acid hydrazide, but not by 3-amino-1,2,4-triazole. The role of mycobacterial catalase-peroxidases in the oxidative activation of the antitubercular prodrug isoniazid is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673210     DOI: 10.1074/jbc.270.38.22290

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Catalase-peroxidases of Legionella pneumophila: cloning of the katA gene and studies of KatA function.

Authors:  P Bandyopadhyay; H M Steinman
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

2.  Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis.

Authors:  B Saint-Joanis; H Souchon; M Wilming; K Johnsson; P M Alzari; S T Cole
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

3.  Role of the oxyferrous heme intermediate and distal side adduct radical in the catalase activity of Mycobacterium tuberculosis KatG revealed by the W107F mutant.

Authors:  Xiangbo Zhao; Shengwei Yu; Kalina Ranguelova; Javier Suarez; Leonid Metlitsky; Johannes P M Schelvis; Richard S Magliozzo
Journal:  J Biol Chem       Date:  2009-01-12       Impact factor: 5.157

Review 4.  Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.

Authors:  Sumit Chakraborty; Kyu Y Rhee
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-15       Impact factor: 6.915

Review 5.  Human catalase: looking for complete identity.

Authors:  Madhur M Goyal; Anjan Basak
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

6.  NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis.

Authors:  L Miesel; T R Weisbrod; J A Marcinkeviciene; R Bittman; W R Jacobs
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

7.  Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.

Authors:  A S Lee; A S Teo; S Y Wong
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

8.  Three-dimensional model and molecular mechanism of Mycobacterium tuberculosis catalase-peroxidase (KatG) and isoniazid-resistant KatG mutants.

Authors:  L Mo; W Zhang; J Wang; X H Weng; S Chen; L Y Shao; M Y Pang; Z W Chen
Journal:  Microb Drug Resist       Date:  2004       Impact factor: 3.431

9.  Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors.

Authors:  Christopher W am Ende; Susan E Knudson; Nina Liu; James Childs; Todd J Sullivan; Melissa Boyne; Hua Xu; Yelizaveta Gegina; Dennis L Knudson; Francis Johnson; Charles A Peloquin; Richard A Slayden; Peter J Tonge
Journal:  Bioorg Med Chem Lett       Date:  2008-04-18       Impact factor: 2.823

Review 10.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.